Quantitative Advantage LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,978 shares of the exchange traded fund’s stock, valued at approximately $268,000.
A number of other hedge funds have also recently bought and sold shares of the business. Reby Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $25,000. Regent Peak Wealth Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $27,000. Litman Gregory Asset Management LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $29,000. Mcmillion Capital Management Inc. bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $30,000. Finally, Pin Oak Investment Advisors Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 56.7% during the fourth quarter. Pin Oak Investment Advisors Inc. now owns 235 shares of the exchange traded fund’s stock valued at $33,000 after acquiring an additional 85 shares during the period.
Shares of XBI stock traded down $0.41 on Friday, reaching $135.68. The company had a trading volume of 140,562 shares, compared to its average volume of 6,808,105. The stock’s 50-day simple moving average is $130.31. SPDR S&P Biotech ETF has a 12 month low of $97.15 and a 12 month high of $174.79.
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More: Trade War
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.